/
Real-world Evidence (RWE) in Japan

Real-world Evidence (RWE) in Japan

Oct 07, 2024

Project Scope 
  • Launch opportunities which are not as formal as academic conferences
  • Plan small events such as seminars presented by free instructors (look for partners, investors and customers) and group work 
  • Distinguish from the opportunities such as The Japan Pharmaceutical Manufacturers Association (JPMA) or The Federation of Pharmaceutical Manufacturers' Associations of JAPAN (FPMAJ)
  • Be a sustainable community which CRO/Medical DB vendors/Pharmaceutical companies can communicate equally, share information and conduct educational activities in Japan. 
Project LeadEmail 
Yosuke Nishida, NTT DataYosuke.Nishida@nttdata.com
Yasunari Sadatsuki, BayerN/A